s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
4
Piacquad David: Statement of changes in beneficial ownership of securities
Filed
Friday, May 29, 2026
Period
May 27, 2026
Accession number
0001610717-26-000171
Documents
form4.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header